Stockwatch: Antibodies And Coronavirus – It’s Complicated
Monoclonal Antibodies Have A Poor Antiviral Track Record
Executive Summary
The use of antibodies in disease prevention and treatment is now ingrained in modern medicine but as antiviral agents their record is at best patchy and the reliance on them to treat or prevent coronavirus infections is perhaps premature.